Therapeutic Advances in Rare Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.503 | Q3 | 61.1% | |
| 2024 | — | — | 0.545 | Q2 | 65.1% | |
| 2023 | — | — | 0.447 | Q3 | 61.3% | |
| 2022 | — | — | — | 0.0% | ||
| 2021 | — | — | — | 0.0% | ||
| 2020 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
2633-0040
region
Western Europe
coverage
2020-2026
